The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus Journal Article


Authors: Robert, S. M.; Reeves, B. C.; Kiziltug, E.; Duy, P. Q.; Karimy, J. K.; Mansuri, M. S.; Marlier, A.; Allington, G.; Greenberg, A. B. W.; DeSpenza, T. Jr; Singh, A. K.; Zeng, X.; Mekbib, K. Y.; Kundishora, A. J.; Nelson-Williams, C.; Hao, L. T.; Zhang, J.; Lam, T. T.; Wilson, R.; Butler, W. E.; Diluna, M. L.; Feinberg, P.; Schafer, D. P.; Movahedi, K.; Tannenbaum, A.; Koundal, S.; Chen, X.; Benveniste, H.; Limbrick, D. D. Jr; Schiff, S. J.; Carter, B. S.; Gunel, M.; Simard, J. M.; Lifton, R. P.; Alper, S. L.; Delpire, E.; Kahle, K. T.
Article Title: The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus
Abstract: The choroid plexus (ChP) is the blood-cerebrospinal fluid (CSF) barrier and the primary source of CSF. Acquired hydrocephalus, caused by brain infection or hemorrhage, lacks drug treatments due to obscure pathobiology. Our integrated, multi-omic investigation of post-infectious hydrocephalus (PIH) and post-hemorrhagic hydrocephalus (PHH) models revealed that lipopolysaccharide and blood breakdown products trigger highly similar TLR4-dependent immune responses at the ChP-CSF interface. The resulting CSF “cytokine storm”, elicited from peripherally derived and border-associated ChP macrophages, causes increased CSF production from ChP epithelial cells via phospho-activation of the TNF-receptor-associated kinase SPAK, which serves as a regulatory scaffold of a multi-ion transporter protein complex. Genetic or pharmacological immunomodulation prevents PIH and PHH by antagonizing SPAK-dependent CSF hypersecretion. These results reveal the ChP as a dynamic, cellularly heterogeneous tissue with highly regulated immune-secretory capacity, expand our understanding of ChP immune-epithelial cell cross talk, and reframe PIH and PHH as related neuroimmune disorders vulnerable to small molecule pharmacotherapy. © 2023 Elsevier Inc.
Keywords: adult; controlled study; protein phosphorylation; unclassified drug; genetics; disease course; nonhuman; pathophysiology; animal cell; metabolism; animal tissue; animal experiment; animal model; enzyme activation; toll like receptor 4; brain; cerebrospinal fluid; rat; blood brain barrier; blood-brain barrier; epithelium cell; lipopolysaccharide; innate immunity; immunity, innate; immunomodulation; tumor necrosis factor receptor; macrophage; phosphotransferase; hydrocephalus; blood flow velocity; cerebrospinal fluid flow; choroid plexus; csf; cytokine storm; pharmacological parameters; humans; human; male; female; article; neuro-inflammation; multiomics; blood-csf barrier; nkcc1; spak; protein spak; cerebrospinal fluid abnormality; post infectious hydrocephalus
Journal Title: Cell
Volume: 186
Issue: 4
ISSN: 0092-8674
Publisher: Cell Press  
Date Published: 2023-02-16
Start Page: 764
End Page: 785.e21
Language: English
DOI: 10.1016/j.cell.2023.01.017
PUBMED: 36803604
PROVIDER: scopus
PMCID: PMC10069664
DOI/URL:
Notes: Article -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors